A new, genetic diagnostic service for ciliopathy disorders has been launched

18 Dec 2015, 1:18 p.m.

In a collaboration between Great Ormond Street Hospital (GOSH) North-East Thames Regional Genetics and the UCL Institute of Child Health, a new genetic diagnostic service for ciliopathy disorders has been launched for service delivery to the NHS.Ciliopathies are rare inherited conditions caused by defects of cilia, hairlike microscopic extensions present on most cells in the human body. Cilia play important roles in development and disease through a diverse number of cell motility and signalling functions. Collectively, ciliopathies cause a significant number of complex and often lethal syndromes with diverse features that include skeletal anomalies, cystic kidney disease, retinal degeneration, obstructive respiratory disease, polydactyly, neurological defects, and problems in left-right axis determination of the internal organs that are associated with heart defects.

A panel of over 120 causal ciliopathy disease genes is now available for screening in affected individuals – in a recent pilot study, more than 60% of well-defined ciliopathy cases were diagnosed using this panel. In parallel, these genes form part of a larger gene panel currently in use in Dr Hannah Mitchison’s lab at ICH for further discovery of new ciliopathy genes. They also form the basis for pre-screening patients prior to entry into the Genomics England 100,000 Genomes Project.

This research was funded by Action Medical Research and GOSH Children’s Charity. Dr Hannah Mitchison is a BRC-supported researcher.

New study finds that nasal cells protect against Covid-19 in children

New research shows that children are less likely than adults to develop severe COVID because cells in their nose are better at fighting off the virus.

New plan announced to get more children access to gene therapy treatments

Great Ormond Street Hospital (GOSH) has announced plans to revolutionise how children living with a rare disease can gain access to life-changing treatments.

First-of-its-kind study into the Ketogenic diet

A ketogenic diet, which is low in carbohydrates and high in fat, shows promise as an alternative treatment option for infants with drug-resistant epilepsy.

Raising awareness on Rare Disease Day

To celebrate Rare Disease Day we invited patients and their families to try out 13 different hands-on and interactive fun and educational science and research activities for children and adults.